Details of the Drug

General Information of Drug (ID: DMKHPA5)

Drug Name

T-Guard

Synonyms

combination

Indication

Disease Entry	ICD 11	Status	REF
Graft-versus-host disease	4B24	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04934670) A Phase 3, Randomized, Open-Label, Multicenter Study, to Compare T-Guard to Ruxolitinib for the Treatment of Patients With Grade III or IV Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD) (BMT CTN 2002). U.S.National Institutes of Health.